P. Arenberger

发表

Light‐activated nanofibre textiles exert antibacterial effects in the setting of chronic wound healing

M. Arenbergerova, M. Bednář, J. Mosinger, 2012, Experimental dermatology.

The EGALITY study: a confirmatory, randomized, double‐blind study comparing the efficacy, safety and immunogenicity of GP2015, a proposed etanercept biosimilar, vs. the originator product in patients with moderate‐to‐severe chronic plaque‐type psoriasis

C. Griffiths, C. Griffiths, K. Kingo, 2017, The British journal of dermatology.

Secukinumab shows high and sustained efficacy in nail psoriasis: 2.5‐year results from the randomized placebo‐controlled TRANSFIGURE study *

B. Elewski, K. Reich, M. Augustin, 2020, The British journal of dermatology.

Effect of secukinumab on the clinical activity and disease burden of nail psoriasis: 32‐week results from the randomized placebo‐controlled TRANSFIGURE trial

K. Reich, M. Augustin, U. Mrowietz, 2019, The British journal of dermatology.

European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022.

A. Lallas, I. Zalaudek, A. Hauschild, 2022, European journal of cancer.

Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countries.

A. Hauschild, R. Dummer, K. Peris, 2018, European Journal of Cancer.

Malignant melanoma in the Czech Republic: incidence and mortality according to sex, age and disease stage.

M. Arenbergerova, A. Vrána, P. Arenberger, 2012, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

Successful treatment of recalcitrant hidradenitis suppurativa with risankizumab after failure of anti‐tumour necrosis factor alpha

M. Arenbergerova, A. Smetanová, P. Arenberger, 2020, The British journal of dermatology.

Elevated serum prolactin levels as a marker of inflammatory arthritis in psoriasis vulgaris.

K. Pavelka, P. Arenberger, Z. Lacinová, 2015, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

Melanoma antigens are biomarkers for ipilimumab response

M. Arenbergerova, I. Puzanov, P. Arenberger, 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

Comparative Study with a Lip Balm Containing 0.5% Propolis Special Extract GH 2002 versus 5% Aciclovir Cream in Patients with Herpes Labialis in the Papular/Erythematous Stage: A Single-blind, Randomized, Two-arm Study

M. Arenbergerova, P. Arenberger, M. Hladíková, 2017, Current therapeutic research, clinical and experimental.

ω-3 Fatty acid–based lipid infusion in patients with chronic plaque psoriasis: Results of a double-blind, randomized, placebo-controlled, multicenter trial

W. Seeger, F. Grimminger, K. Mayer, 1998 .

Temporal arteritis with scalp ulceration and blindness

M. Arenbergerova, P. Arenberger, J. Šach, 2011, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trial.

A. Hauschild, P. Ascierto, R. Dummer, 2017, European journal of cancer.

Diagnosis and treatment of Kaposi's sarcoma: European consensus-based interdisciplinary guideline (EDF/EADO/EORTC).

I. Zalaudek, J. Malvehy, R. Dummer, 2019, European journal of cancer.

Definition of treatment goals for moderate to severe psoriasis: a European consensus

C. Griffiths, T. Nijsten, L. Iversen, 2010, Archives of Dermatological Research.

Stromal Vascular Fraction and its Role in the Management of Alopecia: A Review.

M. Arenbergerova, P. Arenberger, P. Bauer, 2019, The Journal of clinical and aesthetic dermatology.

Killing two birds with one stone: response to pembrolizumab in a patient with metastatic melanoma and B‐cell chronic lymphocytic leukaemia

M. Arenbergerova, P. Arenberger, T. Jirásek, 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.

Development of chronic lymphocytic leukaemia during ipilimumab therapy in a patient with metastatic melanoma

M. Arenbergerova, I. Puzanov, R. Kodet, 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

Characteristics and risk profile of psoriasis patients included in the Czech national registry BIOREP and a comparison with other registries

P. Arenberger, T. Doležal, P. Cetkovska, 2017, International journal of dermatology.

Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma

S. Haferkamp, R. Dummer, J. Kirkwood, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

1037O MASTERKEY-265: A phase III, randomized, placebo (Pbo)-controlled study of talimogene laherparepvec (T) plus pembrolizumab (P) for unresectable stage IIIB–IVM1c melanoma (MEL)

James R. Anderson, J. Kirkwood, A. Ribas, 2021, Annals of Oncology.

Adjuvant nivolumab versus ipilimumab in resected stage IIIB-C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial.

P. Ascierto, J. Larkin, A. Arance, 2020, The Lancet. Oncology.

Quantitative detection of melanoma‐associated antigens by multimarker real‐time RT‐PCR for molecular staging: results of a 5 years study

M. Arenbergerova, P. Arenberger, S. Gkalpakiotis, 2010, Experimental dermatology.

Long‐term impact of adalimumab therapy on biomarkers of systemic inflammation in psoriasis: Results of a 2 year study

M. Arenbergerova, P. Arenberger, P. Kraml, 2020 .

Risankizumab for the Treatment of Moderate-to-Severe Psoriasis: Real-Life Multicenter Experience from the Czech Republic

M. Arenbergerova, P. Arenberger, T. Doležal, 2021, Dermatology and Therapy.

Improvement of atopic dermatitis and IgA nephropathy in a patient treated by dupilumab

M. Arenbergerova, P. Arenberger, I. Rychlík, 2020, Dermatologic therapy.

Oral ponesimod in patients with chronic plaque psoriasis: a randomised, double-blind, placebo-controlled phase 2 trial

S. Chimenti, P. Sator, P. Holló, 2014, The Lancet.

Successful radiotherapy of facial angiosarcoma

M. Arenbergerova, P. Arenberger, O. Vohradníková, 2008, International journal of dermatology.

Effect of topical heparin and levomenol on atopic dermatitis: a randomized four‐arm, placebo‐controlled, double‐blind clinical study

M. Arenbergerova, P. Arenberger, M. Hladíková, 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.

The HLA-Cw*06 allele and −1149 G/T polymorphism of extrapituitary promoter of PRL gene as a possible common genetic predisposing factors to psoriasis vulgaris and psoriatic arthritis in Czech population

M. Černá, P. Arenberger, L. Šedová, 2013, Rheumatology International.

Demographic data, comorbidities, quality of life, and survival probability of biologic therapy associated with sex‐specific differences in psoriasis in the Czech Republic

P. Arenberger, P. Cetkovska, M. Kojanova, 2021 .

Use of biologics for psoriasis in Central and Eastern European countries

L. Kemény, M. Niewada, G. Petrova, 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

Adjuvant nivolumab versus ipilimumab (CheckMate 238 trial): Reassessment of 4-year efficacy outcomes in patients with stage III melanoma per AJCC-8 staging criteria.

P. Ascierto, A. Arance, P. Queirolo, 2022, European journal of cancer.

A phase IIIb, multicentre, randomized, double‐blind, vehicle‐controlled study of the efficacy and safety of adalimumab with and without calcipotriol/betamethasone topical treatment in patients with moderate to severe psoriasis: the BELIEVE study

J. Saurat, S. Chimenti, J. Ortonne, 2010, The British journal of dermatology.

Impact of adalimumab treatment on cardiovascular risk biomarkers in psoriasis: Results of a pilot study

M. Arenbergerova, P. Arenberger, P. Kraml, 2017, The Journal of dermatology.

Real-life experience in the effectiveness, impact on quality of life and safety of dupilumab treatment in patients with moderate to severe atopic dermatitis in the Czech Republic.

M. Arenbergerova, P. Arenberger, T. Doležal, 2022, Central European journal of public health.

Dupilumab therapy in a patient with atopic dermatitis and severe atopic keratoconjunctivitis

M. Arenbergerova, P. Arenberger, P. Skalicka, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

Regulation of 12(S)-hydroxyeicosatetraenoic acid (12(S)-HETE) binding sites on human epidermal cells by interferon-gamma.

T. Ruzicka, P. Arenberger, E. Gross, 1990, Experimental cell research.

Dead Sea climatotherapy versus topical steroid treatment for atopic dermatitis children: long-term follow-up study

A. Kudish, P. Arenberger, M. Harari, 2019, The Journal of dermatological treatment.

Coexistence of palmoplantar pustulosis and ichthyosis vulgaris treated by risankizumab

M. Arenbergerova, P. Arenberger, S. Gkalpakiotis, 2021, The British journal of dermatology.

Corticosteroid rescue therapy in relapsing hidradenitis suppurativa treated with adalimumab

M. Arenbergerova, A. Smetanová, P. Arenberger, 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

The lipoxygenase inhibitor 2-phenylmethyl-1-naphthol (DuP 654) is a 12(S)-hydroxyeicosatetraenoic acid receptor antagonist in the human epidermal cell line SCL-II.

L. Kemény, T. Ruzicka, P. Arenberger, 1993, Skin Pharmacology.

Severe diclofenac photoallergy in a patient treated with vemurafenib

M. Arenbergerova, P. Arenberger, J. Ettler, 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

Interleukin‐8 receptor‐mediated chemotaxis of normal human epidermal cells

L. Kemény, T. Ruzicka, P. Arenberger, 1992, FEBS letters.

Increased sensitivity and high specificity of indirect immunofluorescence in detecting IgG subclasses for diagnosis of bullous pemphigoid

T. Ruzicka, M. Sárdy, P. Arenberger, 2018, Clinical and experimental dermatology.

Photodynamic Therapy of Necrobiosis Lipoidica – A Multicenter Study of 18 Patients

C. Berking, G. Jemec, T. Ruzicka, 2008, Dermatology.

Severe exacerbation of psoriasis after intravenous immunoglobulin in patient with multiple sclerosis that started during biologic therapy

M. Arenbergerova, P. Arenberger, J. Ettler, 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

Towards optimization of an organotypic assay system that imitates human hair follicle‐like epithelial–mesenchymal interactions

R. Paus, T. Bíró, A. Mescalchin, 2004, The British journal of dermatology.

European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics - Update 2019.

A. Lallas, I. Zalaudek, A. Hauschild, 2020, European journal of cancer.

European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2019.

Giovanni Pellacani, Josep Malvehy, Axel Hauschild, 2019, European journal of cancer.

Darier disease complicated by severe Kaposi varicelliform eruption resistant to acyclovir

M. Arenbergerova, R. Zajíček, P. Arenberger, 2020, Dermatologic therapy.

Macrolide treatment failure in a case of secondary syphilis: a novel A2059G mutation in the 23S rRNA gene of Treponema pallidum subsp. pallidum.

G. Weinstock, D. Šmajs, P. Arenberger, 2009, Journal of medical microbiology.

European S3‐Guidelines on the systemic treatment of psoriasis vulgaris – Update 2015 – Short version – EDF in cooperation with EADV and IPC

P. Gisondi, K. Papp, K. Reich, 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

Long‐term therapy with ustekinumab for psoriasis in a patient with a history of malignant melanoma

M. Arenbergerova, P. Arenberger, S. Gkalpakiotis, 2017, Dermatologic therapy.

Defect of epidermal 12(S)‐hydroxyeicosatetraenoic acid receptors in psoriasis

L. Kemény, T. Ruzicka, P. Arenberger, 1992, European journal of clinical investigation.

Long-term Survival with Ipilimumab: Experience from a National Expanded Access Program for Patients with Melanoma.

A. Poprach, B. Melichar, I. Krajsová, 2015, Anticancer research.

European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022.

A. Lallas, I. Zalaudek, A. Hauschild, 2022, European journal of cancer.

Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countries.

A. Hauschild, R. Dummer, K. Peris, 2018, European journal of cancer.

Vismodegib (VISMO), a hedgehog pathway inhibitor (HPI), in advanced basal cell carcinoma (aBCC): STEVIE study primary analysis in 1215 patients (pts).

A. Hauschild, P. Ascierto, R. Dummer, 2016 .

Which medical disciplines diagnose and treat melanoma in Europe in 2019? A survey of experts from melanoma centres in 27 European countries

R. Karls, A. Lallas, J. Paoli, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

The evolving field of Dermato‐oncology and the role of dermatologists: Position Paper of the EADO, EADV and Task Forces, EDF, IDS, EBDV–UEMS and EORTC Cutaneous Lymphoma Task Force

A. Enk, M. Arenbergerova, A. Lallas, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

Multiple switches between GP2015, an etanercept biosimilar, with originator product do not impact efficacy, safety and immunogenicity in patients with chronic plaque‐type psoriasis: 30‐week results from the phase 3, confirmatory EGALITY study

D. Thaçi, C. Griffiths, P. Arenberger, 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

COVID-19 in 3 patients treated with immune checkpoint inhibitors for advanced melanoma

M. Arenbergerova, P. Arenberger, A. Fialova, 2020, The Journal of dermatological treatment.

ABD-Derived Protein Blockers of Human IL-17 Receptor A as Non-IgG Alternatives for Modulation of IL-17-Dependent Pro-Inflammatory Axis

J. Černý, R. Osicka, M. Kuchař, 2018, International journal of molecular sciences.

Gene expression in actinic keratoses: pharmacological modulation by imiquimod

T. Ruzicka, B. Benninghoff, P. Arenberger, 2004, The British journal of dermatology.

Long-Term Efficacy, Safety, and Drug Survival of Guselkumab in Patients with Psoriasis: Real-World Data from the Czech Republic BIOREP Registry

J. Sevcík, H. Bučková, M. Tichý, 2023, Dermatology and Therapy.

Inhibition of 12(S)-hydroxyeicosatetraenoic acid [12(S)-HETE] binding to epidermal cells by ultraviolet-B.

L. Kemény, T. Ruzicka, B. Przybilla, 1991, The Journal of investigative dermatology.

Adjuvant nivolumab for stage III/IV melanoma: evaluation of safety outcomes and association with recurrence-free survival

P. Ascierto, M. Del Vecchio, M. Mandalà, 2021, Journal for ImmunoTherapy of Cancer.

The treatment of unilesional mycosis fungoides with methyl aminolevulinate‐photodynamic therapy

P. Arenberger, J. Hegyi, T. Frey, 2008, Journal of the European Academy of Dermatology and Venereology : JEADV.

Primary cutaneous lymphomas in dermatological practice

P. Arenberger, J. Polívka, J. Ettler, 2018, Onkologie.

Deroofing followed by thorough sinus tract excision: a modified surgical approach for hidradenitis suppurativa

M. Arenbergerova, P. Arenberger, S. Gkalpakiotis, 2019, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Palladium causes bizarre skin hyperpigmentation in long‐term dihydrocodeinone ‘Braun’ abusers

M. Arenbergerova, P. Arenberger, O. Trhlíková, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

Incidence of cutaneous malignant melanoma in the Czech Republic: the risks of sun exposure for adolescents.

M. Arenbergerova, A. Vrána, P. Arenberger, 2012, Neoplasma.

Long‐term combination therapy of ustekinumab and dapsone in a patient with psoriasis and dermatitis herpetiformis Duhring

M. Arenbergerova, P. Arenberger, E. Sticova, 2012, The Journal of dermatology.

Toxic epidermal necrolysis induced by vemurafenib after nivolumab failure

M. Arenbergerova, I. Mrázová, P. Arenberger, 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

Acute bronchitis therapy with ivy leaves extracts in a two-arm study. A double-blind, randomised study vs. an other ivy leaves extract.

P. Arenberger, B. Ottillinger, Ute Cwientzek, 2011, Phytomedicine : international journal of phytotherapy and phytopharmacology.

Psoriasis treatment with adalimumab in clinical practice: long-term experience in a center for biological therapy in the Czech Republic

M. Arenbergerova, P. Arenberger, T. Doležal, 2018, The Journal of dermatological treatment.

Employing Adalimumab in Treatment of Moderate-to-Severe Hidradenitis Suppurativa: Real-Life Multicenter Data from the Czech Republic

M. Arenbergerova, P. Arenberger, E. Marques, 2023, Dermatologic Therapy.

Disease burden and treatment history among adults with atopic dermatitis receiving systemic therapy: baseline characteristics of participants on the EUROSTAD prospective observational study

T. Agner, A. Pink, S. Ferrucci, 2021, The Journal of dermatological treatment.

Down-regulation of epidermal growth factor receptors by dithranol.

L. Kemény, T. Ruzicka, P. Arenberger, 1993, Acta dermato-venereologica.

Substance P binding in normal neonatal foreskin

E. Farber, P. Arenberger, R. O. Leder, 1995, The British journal of dermatology.

A. Menter, S. Beissert, P. Arenberger, 2020, Expert opinion on biological therapy.

1130TiPNEMO: A PHASE 3 TRIAL OF BINIMETINIB (MEK162) VERSUS DACARBAZINE IN PATIENTS WITH ADVANCED NRAS-MUTANT MELANOMA WHO ARE UNTREATED OR HAVE PROGRESSED AFTER ANY NUMBER OF IMMUNOTHERAPY REGIMENS.

D. Schadendorf, K. Flaherty, P. Ascierto, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Management of psoriasis vulgaris and multiple sclerosis with fumaric acid.

M. Arenbergerova, P. Arenberger, E. Meluzínová, 2014, Journal of the American Academy of Dermatology.

Effective long‐term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapy

M. Arenbergerova, P. Arenberger, S. Gkalpakiotis, 2010, International journal of dermatology.

Quantitative changes of melanoma‐associated antigens as a biomarker for targeted therapy response

M. Arenbergerova, P. Arenberger, A. Fialova, 2016, Experimental dermatology.

A survey of disease severity, quality of life, and treatment patterns of biologically naive patients with psoriasis in central and eastern Europe.

J. Szepietowski, Ene Pärna, C. Giurcaneanu, 2010, Acta dermatovenerologica Croatica : ADC.

Dithranol-induced down-regulation of 12(S)-hydroxyeicosatetraenoic acid [12(S)-HETE] receptors in a human epidermal cell line

L. Kemény, T. Ruzicka, P. Arenberger, 2004, Archives of Dermatological Research.

Calcipotriene and Betamethasone Dipropionate PAD-Cream Demonstrates Greater Treatment Efficacy in Patients with Moderate-to-Severe Psoriasis Compared to Topical Suspension/Gel: A Subgroup Analysis of Two Phase 3 Studies

M. Praestegaard, P. Arenberger, L. Stein Gold, 2023, Dermatology and Therapy.

European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma-update 2023.

A. Lallas, I. Zalaudek, A. Hauschild, 2023, European journal of cancer.

Characterization of high-affinity 12(S)-hydroxyeicosatetraenoic acid (12(S)-HETE) binding sites on normal human keratinocytes.

L. Kemény, T. Ruzicka, P. Arenberger, 1993, Epithelial cell biology.

European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention-Update 2023.

A. Lallas, I. Zalaudek, A. Hauschild, 2023, European journal of cancer.

Eruptive multiple Spitz nevi in a patient with epilepsy and drug addiction

M. Arenbergerova, P. Arenberger, S. Gkalpakiotis, 2011, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment-Update 2023.

A. Lallas, I. Zalaudek, A. Hauschild, 2023, European journal of cancer.

Guidelines on the use of extracorporeal photopheresis

A. Enk, C. Klemke, H. Pehamberger, 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

Adjuvant therapy with nivolumab versus placebo in patients with resected stage IIB/C melanoma (CheckMate 76K)

P. Ascierto, J. Kirkwood, P. Durani, 2023, SKIN The Journal of Cutaneous Medicine.

Real-World Evidence From More Than 1000 Patients Treated With Adalimumab For Moderate-to-Severe Psoriasis in the Czech Republic

J. Sevcík, J. Štork, M. Tichý, 2021, Dermatology and Therapy.

New developments in fluorescence diagnostics

Carola Berking, Thomas Ruzicka, C. Berking, 2011, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Current therapeutical options in primary cutaneous T-cell lymphomas

P. Arenberger, J. Polívka, J. Ettler, 2018 .

Baseline factors affecting closure of venous leg ulcers.

R. Kirsner, M. Weichenthal, Stephanie Wu, 2017, Journal of vascular surgery. Venous and lymphatic disorders.

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III/IV Melanoma: 5-Year Efficacy and Biomarker Results from CheckMate 238

P. Ascierto, A. Arance, P. Queirolo, 2023, Clinical cancer research : an official journal of the American Association for Cancer Research.

Langerhans cells of the human skin possess high‐affinity 12(S)‐hydroxyeicosa tetraenoic acid receptors

T. Bieber, R. Rupec, L. Kemény, 1992, European journal of immunology.

Acrodermatitis continua Hallopeau successfully treated by risankizumab

M. Arenbergerova, P. Arenberger, S. Gkalpakiotis, 2020, International journal of dermatology.

Confocal laser‐scanning capillaroscopy: a novel approach to the analysis of skin capillaries in vivo

C. Berking, T. Ruzicka, P. Arenberger, 2009, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging.

Randomized Phase 3 trial demonstrating high efficacy, favourable safety and convenience of a novel calcipotriol and betamethasone dipropionate cream for the treatment of psoriasis

M. Praestegaard, P. Arenberger, A. Pinter, 2023, Journal of the European Academy of Dermatology and Venereology : JEADV.

Unusual Periungual Nodulocystic Lesions Leading to the Diagnosis of Extranodal Marginal Zone Lymphoma

M. Arenbergerova, P. Arenberger, S. Gkalpakiotis, 2020, Indian journal of dermatology.